Last month, company leaders visited our Monza, Italy site for the grand opening of our brand-new drug product Training Center & Aseptic Academy. With guidance from our local subject matter experts, Executive Vice President and Chief Operating Officer Michel Lagarde, Drug Product President Simona Fugazza and Vice President and General Manager for Drug Product EU and APAC Alexandre Pasini got to experience simulated elements of our drug product aseptic training in Virtual Reality (VR). Not only is VR-based education an impactful way for our Thermo Fisher Scientific colleagues to learn critical operational and quality processes in a safe environment, but it also allows them to continue running machines on the floor at the same time. Rather than pausing production for training, our teams are building their skills while continuously delivering for our customers. We have invested to roll out this training program across multiple Thermo Fisher sites supporting our pharma services, starting with our dedicated training centers in Greenville, NC, US, and Monza. Stay tuned for more on this application of #innovation and cutting-edge technology. To learn more about our Monza site, visit: https://lnkd.in/eH9w-7nV
Earlier this month, our site in Monza, Italy celebrated the grand opening of our local Training Center & Aseptic Academy. It’s a cutting-edge space that leverages augmented and virtual reality (AR/VR) to provide colleagues working across our #Steriles manufacturing capabilities – from operations to quality – with the opportunity to train in both hands-on and simulated Good Manufacturing Practice (GMP) environments. Thermo Fisher Scientific leaders – including Executive Vice President and Chief Operating Officer Michel Lagarde, Drug Product President Simona Fugazza and Vice President and General Manager for Drug Product EU and APAC Alexandre Pasini – attended the event.